Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

SHE:002412 Revenue

Hunan Hansen Pharmaceutical had revenue of 263.23M CNY in the quarter ending March 31, 2026, a decrease of -2.25%. This brings the company's revenue in the last twelve months to 1.03B, up 1.27% year-over-year. In the year 2025, Hunan Hansen Pharmaceutical had annual revenue of 1.04B with 3.41% growth.

• Revenue (ttm): 1.03B
• Revenue Growth: +1.27%
• P/S Ratio: 3.03
• Revenue / Employee: 489.89K
• Employees: 1,675
• Market Cap: 3.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.04B	34.29M	3.41%
Dec 31, 2024	1.00B	48.94M	5.12%
Dec 31, 2023	955.53M	39.47M	4.31%
Jan 1, 2023	916.06M	24.23M	2.72%
Jan 1, 2022	891.84M	150.60M	20.32%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error